康泰医学
(300869)
| 流通市值：32.59亿 | | | 总市值：49.58亿 |
| 流通股本：2.64亿 | | | 总股本：4.02亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,041,280,114.13 | 982,722,811.09 | 777,858,965.4 | 737,467,276.65 |
| 交易性金融资产 | 762,353,589.43 | 631,773,267.48 | 633,329,630.79 | 642,752,724.31 |
| 应收票据及应收账款 | 36,477,045.47 | 50,045,443.04 | 47,427,303.91 | 39,604,096.77 |
| 其中：应收票据 | - | 0 | - | - |
| 应收账款 | 36,477,045.47 | 50,045,443.04 | 47,427,303.91 | 39,604,096.77 |
| 预付款项 | 9,329,948.3 | 7,551,950.04 | 14,711,719.11 | 11,926,516.26 |
| 其他应收款合计 | 10,307,655.3 | 7,082,216.1 | 9,959,905.51 | 21,182,006.78 |
| 存货 | 236,620,428.47 | 229,580,801.36 | 267,770,551.4 | 277,275,030.66 |
| 一年内到期的非流动资产 | 249,850,214.28 | 411,740,927.18 | 603,599,819.42 | 590,263,484.59 |
| 其他流动资产 | 22,805,755.84 | 23,253,638.6 | 20,857,106.78 | 20,910,099.88 |
| 流动资产合计 | 2,369,024,751.22 | 2,343,751,054.89 | 2,375,515,002.32 | 2,341,381,235.9 |
| 非流动资产: | | | | |
| 投资性房地产 | 59,579,141.54 | 60,215,442.14 | 58,984,272.89 | 59,621,815.82 |
| 固定资产 | 198,913,281.59 | 203,253,388.04 | 198,034,517.45 | 198,343,646.65 |
| 在建工程 | 106,104,575.69 | 102,298,519.05 | 98,224,541.71 | 89,318,209.48 |
| 使用权资产 | 3,196,060.78 | 3,577,051.45 | 3,507,203.73 | 3,019,096.67 |
| 无形资产 | 49,007,953.83 | 49,695,552.9 | 50,386,102.05 | 50,719,719.05 |
| 长期待摊费用 | 41,051.82 | 46,531.56 | 52,011.3 | 73,583.85 |
| 递延所得税资产 | 7,960,620.04 | 7,134,495.83 | 6,181,816.42 | 5,078,031.59 |
| 其他非流动资产 | 535,194.35 | 1,220,163.38 | - | 21,295,926.61 |
| 非流动资产合计 | 425,337,879.64 | 427,441,144.35 | 415,370,465.55 | 427,470,029.72 |
| 资产总计 | 2,794,362,630.86 | 2,771,192,199.24 | 2,790,885,467.87 | 2,768,851,265.62 |
| 流动负债: | | | | |
| 短期借款 | 224,575,849.63 | 215,000,000 | 197,000,000 | 165,000,000 |
| 应付票据及应付账款 | 21,922,373.46 | 11,465,549.27 | 20,929,884.79 | 22,772,574.24 |
| 应付账款 | 21,922,373.46 | 11,465,549.27 | 20,929,884.79 | 22,772,574.24 |
| 合同负债 | 40,134,002 | 30,629,857.47 | 34,110,571.94 | 34,517,114.42 |
| 应付职工薪酬 | 11,133,365.27 | 12,232,117.62 | 12,374,014.52 | 13,095,786.95 |
| 应交税费 | 1,023,086.06 | 1,850,261.76 | 5,124,529.52 | 5,601,405.82 |
| 其他应付款合计 | 3,881,970.72 | 7,236,242.39 | 4,199,878.83 | 3,334,501.45 |
| 一年内到期的非流动负债 | 1,148,159.36 | 1,082,159.53 | 1,612,511.2 | 1,135,904.15 |
| 流动负债合计 | 303,818,806.5 | 279,496,188.04 | 275,351,390.8 | 245,457,287.03 |
| 非流动负债: | | | | |
| 应付债券 | 757,689,095.64 | 749,141,453.98 | 740,464,397.83 | 740,255,459.52 |
| 租赁负债 | 1,847,486.17 | 2,258,289.25 | 1,644,894.58 | 1,642,150.31 |
| 递延收益 | 6,853,049.17 | 7,088,500.22 | 7,245,998.25 | 7,416,356.89 |
| 递延所得税负债 | 49,249.64 | 58,155.81 | 52,817.84 | 51,713.5 |
| 非流动负债合计 | 766,438,880.62 | 758,546,399.26 | 749,408,108.5 | 749,365,680.22 |
| 负债合计 | 1,070,257,687.12 | 1,038,042,587.3 | 1,024,759,499.3 | 994,822,967.25 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 401,803,327 | 401,803,197 | 401,803,194 | 401,802,977 |
| 其他权益工具 | 29,613,425.46 | 29,613,615.22 | 29,613,620.49 | 29,613,936.75 |
| 资本公积 | 352,350,423.02 | 352,346,523.87 | 352,346,415.98 | 352,340,023.82 |
| 其他综合收益 | 1,893,656.29 | 2,700,393.92 | 3,081,067.01 | 3,451,958.94 |
| 专项储备 | 4,697,342.35 | 4,697,342.35 | 3,469,428.06 | 3,469,428.06 |
| 盈余公积 | 174,456,618.55 | 174,456,618.55 | 174,456,618.55 | 174,456,618.55 |
| 未分配利润 | 759,290,151.07 | 767,531,921.03 | 801,355,624.48 | 808,893,355.25 |
| 归属于母公司股东权益合计 | 1,724,104,943.74 | 1,733,149,611.94 | 1,766,125,968.57 | 1,774,028,298.37 |
| 股东权益合计 | 1,724,104,943.74 | 1,733,149,611.94 | 1,766,125,968.57 | 1,774,028,298.37 |
| 负债和股东权益合计 | 2,794,362,630.86 | 2,771,192,199.24 | 2,790,885,467.87 | 2,768,851,265.62 |
| 公告日期 | 2026-04-28 | 2026-04-28 | 2025-10-30 | 2025-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |